Managers
Japanese stocks were the highlight at the annual Sohn Hong Kong Investment Leaders Conference, as well as those from South Korea and Rio Tinto Group, the world’s second largest metals and mining company.
Simon Sadler’s $4.8bn Asian hedge fund Segantii Capital Management has said it will wind down and return capital to its investors “in an orderly manner”, with about 140 employees across Hong Kong, New York and London affected by the decision.
Sydney-based Caledonia, one of Australia’s largest and most secretive hedge funds, is maintaining a highly concentrated bet in Zillow Group, forecasting a rebound after the US real estate listing company’s shares plummeted over 26% this year, according to a report by Bloomberg.
Cliff Asness, co-founder of quant hedge fund firm AQR Capital Management, considers the rise of generative AI to be “evolutionary, not revolutionary”, emphasising that despite the hype, AI is “still just statistics”, according to a report by Pensions & Investments.
Hedge funds are cutting their stakes in large-cap technology stocks, shifting their focus to a broader range of companies that are involved in, or stand to benefit from advancements in AI, according to analysis from Goldman Sachs.
Global hedge funds have increased their holdings of Chinese equities for the fourth consecutive week, joining the growing number of investors anticipating a market rebound, according to a report by Reuters citing a note from Goldman Sachs’ prime brokerage team.
Izzy Englander, founder of the $61bn New York-based hedge fund Millennium Management, appears to be increasingly confident that the share price of international sports betting and gambling company Flutter Entertainment is set to decrease, according to a report by The Irish Times.
London-based crypto hedge funds are experiencing significant gains this year, reflecting growing market optimism for digital assets, according to a report by Financial News.
Two funds previously controlled by Odey Asset Management saw strong performances, ranking them among the top 10 best performing funds globally in April, according to data from Société Générale.
Hedge fund Shah Capital will end its proxy campaign against the re-election of three broad directors at Covid-19 vaccine maker Novavax after the company signed a licensing deal with French drugmaker Sanofi.
